Compound ID | Pharmacological profile | Compound name | Binding data | Activity data | Bibliographic ref | Cross-reactivity | |
ZINC01490075 | agonist | Compound (S,S)-2b | RBA = 14 +/- 4 % | PMID: 10395487 | ER_alpha | ||
ZINC13557154 | agonist | Compound trans-3a | RBA = 254 +/- 57 % | PMID: 10395487 | ER_alpha | ||
ZINC03926298 | antagonist | fulvestrant | IC50 = 7+/-3 nM | IC50 = 0.72 +/- 0.2 nM (100%) | PMID: 10673099 | ER_alpha | |
ZINC28262868 | antagonist | Compound 27 | RBA = 0.06 % | PMID: 11392537 | |||
ZINC28264205 | antagonist | Compound 21 | RBA = 10 % | PMID: 11392537 | ER_alpha | ||
CHEMBL58563 | antagonist | Compound 4 | Ki = 680 +/- 190 nM | IC50 = 160 nM | PMID: 11459665 | ||
CHEMBL132868 | agonist | Compound 64a | RBA = 22 +/- 4 % | EC50 = 2.0 nM | PMID: 11708925 | ER_alpha | |
CHEMBL133203 | agonist | Compound 69 | RBA = 1.3 % | EC50 = 160 nM | PMID: 11708925 | ER_alpha | |
CHEMBL134646 | agonist | Compound 27 | RBA = 6.6 +/- 1.9 % | EC50 = 8.0 nM | PMID: 11708925 | ER_alpha | |
CHEMBL135597 | agonist | Compound 16h | RBA = 18 +/- 3 % | EC50 = 1.7 nM | PMID: 11708925 | ER_alpha | |
CHEMBL135649 | agonist | Compound 71 | RBA = 2.3 % | EC50 = 35 nM | PMID: 11708925 | ER_alpha | |
CHEMBL135695 | agonist | Compound 16g | RBA = 60 +/- 11% | EC50 = 0.37 nM | PMID: 11708925 | ER_alpha | |
CHEMBL136039 | agonist | Compound 42b | RBA = 43 +/- 7 % | EC50 = 2.1 nM | PMID: 11708925 | ER_alpha | |
CHEMBL334773 | agonist | DPN | RBA = 18 +/- 2 % | EC50 = 0.85 nM | PMID: 11708925 | ER_alpha | |
CHEMBL334798 | agonist | Compound 42a | RBA = 78 +/- 10% | EC50 = 1.4 nM | PMID: 11708925 | ER_alpha | |
CHEMBL335412 | agonist | Compound 66 | RBA = 8.3 +/- 1.2 % | EC50 = 4.9 nM | PMID: 11708925 | ER_alpha | |
CHEMBL335620 | agonist | Compound 64b | RBA = 35 +/- 10 % | EC50 = 15 nM | PMID: 11708925 | ER_alpha | |
CHEMBL342418 | agonist | Compound meso-31a | RBA = 29 +/- 7 % | EC50 = 0.42 nM | PMID: 11708925 | ER_alpha | |
ZINC01698387 | agonist | Compound (E)-37 | RBA = 82 +/- 4 % | EC50 = 220 nM | PMID: 11708925 | ER_alpha | |
ZINC05923210 | agonist | Compound 29b | RBA = 75 +/- 6 % | EC50 = 0.15 nM | PMID: 11708925 | ER_alpha | |
ZINC13470332 | agonist | Compound 25 | RBA = 2.2 % | EC50 = 30 nM | PMID: 11708925 | ER_alpha | |
ZINC13470338 | agonist | Compound dl-31a | RBA =2.8 +/- 0.8 % | EC50 = 0.41 nM | PMID: 11708925 | ER_alpha | |
ZINC13470339 | agonist | Compound erythro-31b | RBA = 3.4 % | EC50 = 110 nM | PMID: 11708925 | ER_alpha | |
ZINC13470340 | agonist | Compound 35 | RBA = 2.5 +/- 0.7 % | EC50 = 21 nM | PMID: 11708925 | ER_alpha | |
ZINC13470347 | agonist | Compound dl-54 | RBA = 14 +/- 4% | EC50 = 3.7 nM | PMID: 11708925 | ER_alpha | |
ZINC13674162 | agonist | Compound 29a | RBA = 48 +/- 3 % | EC50 = 0.14 nM | PMID: 11708925 | ER_alpha | |
ZINC17327767 | agonist | Compound (Z)-36 | RBA =17 +/- 3 % | EC50 = 140 nM | PMID: 11708925 | ER_alpha | |
ZINC03581478 | agonist | Compound 3 | EC50 = 114 nM | EC50 = 17 nM | PMID: 11906280 | ||
ZINC13472829 | agonist | Compound 1 | EC50 = 4310 nM | EC50 = 166 nM | PMID: 11906280 | ||
ZINC13472831 | agonist | Compound 4 | EC50 = 115 nM | EC50 = 32 nM | PMID: 11906280 | ||
ZINC13472832 | agonist | Compound 5 | EC50 = 1830 nM | EC50 = 302 nM | PMID: 11906280 | ||
ZINC13472833 | agonist | Compound 6 | EC50 = 4710 nM | EC50 = 257 nM | PMID: 11906280 | ||
ZINC13472834 | agonist | Compound 7 | EC50 = 3940 nM | EC50 = 186 nM | PMID: 11906280 | ||
ZINC13472835 | agonist | Compound 8 | EC50 = 249 nM | EC50 = 525 nM | PMID: 11906280 | ||
ZINC13472836 | agonist | Compound 9 | EC50 = 740 nM | EC50 = 245 nM | PMID: 11906280 | ||
ZINC13472838 | agonist | Compound 11 | EC50 = 129 nM | EC50 = 15 nM | PMID: 11906280 | ||
ZINC13400121 | agonist | Compound 4 | PMID: 12350164 | ER_alpha | |||
ZINC14819371 | agonist | Compound 3 | PMID: 12350164 | ER_alpha | |||
ZINC14819381 | agonist | Compound 2 | PMID: 12350164 | ER_alpha | |||
ZINC01553578 | antagonist | Compound 15 | Ki = 15+/-10 nM | IC50 = 6 +/- 2 nM (103 +/- 6%) | PMID: 12459017 | ||
ZINC13492566 | antagonist | Compound 21 | Ki = 15 +/- 2 nM | IC50 = 15 +/- 5 nM (98 +/- 5%) | PMID: 12459017 | ||
ZINC13492576 | antagonist | Compound 31 | Ki = 40 +/- 15 nM | IC50 = 20 +/- 3 nM (93 +/- 2%) | PMID: 12459017 | ||
ZINC27630210 | antagonist | Compound 43 | Ki = 25 +/ 10 nM | IC50 = 5 +/- 2 nM (98 +/- 2%) | PMID: 12459017 | ||
ZINC27633960 | antagonist | Compound 17 | Ki = 15 +/- 9 nM | IC50 = 5 +/- 1 nM (112 +/- 5%) | PMID: 12459017 | ||
CHEMBL512579 | antagonist | Compound 1 | IC50 = 0.88 +/- 0.004 µM | IC50 = 10.5 +/- 5.0 µM | PMID: 12502307 | ||
CHEMBL296018 | antagonist | Compound 10 | RBA = 35 +/- 7 % | PMID: 12699377 | ER_alpha | ||
CHEMBL43246 | antagonist | Compound 9 | RBA = 52 +/- 11 % | PMID: 12699377 | |||
CHEMBL43636 | antagonist | Compound 11 | RBA = 187 +/- 44 % | PMID: 12699377 | |||
CHEMBL44565 | antagonist | Compound 32 | RBA = 189 +/- 15 % | PMID: 12699377 | |||
CHEMBL6619 | antagonist | Compound 36 | RBA = 334 +/- 54 % | PMID: 12699377 | |||
ZINC12353793 | antagonist | Compound 16 | RBA = 211 +/- 57 % | PMID: 12699377 | |||
ZINC13517894 | antagonist | Compound 14 | RBA = 317 +/- 31 % | PMID: 12699377 | |||
ZINC13517909 | antagonist | Compound 8 | RBA = 301 +/- 54 % | PMID: 12699377 | |||
ZINC13517915 | antagonist | Compound 18 | RBA = 125 +/- 22 % | PMID: 12699377 | |||
ZINC03991700 | agonist | E15-1,2 (50) | RBA = 7 +/- 2 % | RSA = 18 +/- 10 % | PMID: 12723952 | ER_alpha | |
ZINC13518409 | agonist | E7α-1,2 (9) | RBA = 9 +/- 2 % | RSA = 15 +/- 12 % | PMID: 12723952 | ER_alpha | |
CHEMBL294889 | agonist | Compound 2 | IC50 = 850 nM | %agonist = 149 % | PMID: 12749898 | ER_alpha | |
ZINC13490127 | agonist | Compound 3 | IC50 = 75 nM | %agonist = 139 % | PMID: 12749898 | ER_alpha | |
CHEMBL311878 | agonist | Compound 6 | IC50 = 42 +/- 24 nM | EC50 = 18 nM | PMID: 12824043 | ||
CHEMBL103650 | agonist | Compound 27 | IC50 = 421 +/ 5 nM | EC50 = 1 nM | PMID: 12825935 | ER_alpha | |
ZINC03831614 | agonist | alpha-zearalanol | EC50 = 24 nM | PMID: 12828470 | |||
ZINC03831616 | agonist | beta-zearalanol | EC50 = 72 nM | PMID: 12828470 | |||
ZINC03898789 | agonist | zearalenone | EC50 = 110 nM | PMID: 12828470 | |||
ZINC04655389 | agonist | alpha-zearalenol | EC50 = 38 nM | PMID: 12828470 | |||
ZINC04655390 | agonist | beta-zearalenol | EC50 = 220 nM | PMID: 12828470 | |||
ZINC04655391 | agonist | zearalanone | EC50 = 660 nM | PMID: 12828470 | |||
ZINC13560486 | antagonist | Compound 6 | IC50 = 2049 nM | inhibition = 50% | PMID: 15006374 | ER_alpha | |
ZINC29215330 | antagonist | Compound 11 | IC50 = 546 nM | inhibition = 46% | PMID: 15006374 | ER_alpha | |
CHEMBL264862 | agonist | Compound 4i | IC50 = 310 nM | EC50 = 47 nM | PMID: 15081034 | ER_alpha | |
CHEMBL306636 | agonist | Compound 4d | IC50 = 320 nM | EC50 = 18 nM | PMID: 15081034 | ER_alpha | |
CHEMBL74757 | agonist | Compound 4b | IC50 = 330 nM | EC50 = 30 nM | PMID: 15081034 | ER_alpha | |
CHEMBL74758 | agonist | Compound 4c | IC50 = 200 nM | EC50 = 7 nM | PMID: 15081034 | ER_alpha | |
CHEMBL77466 | agonist | Compound 4k | IC50 = 1100 nM | EC50 = 180 nM | PMID: 15081034 | ER_alpha | |
CHEMBL77609 | agonist | Compound 4n | IC50 = 90 nM | EC50 = 8 nM | PMID: 15081034 | ER_alpha | |
CHEMBL77620 | agonist | Compound 4m | IC50 = 90 nM | EC50 = 16 nM | PMID: 15081034 | ER_alpha | |
CHEMBL77930 | agonist | Compound 4j | IC50 = 120 nM | EC50 = 26 nM | PMID: 15081034 | ER_alpha | |
ZINC12353741 | agonist | Compound 4g | IC50 = 1400 nM | EC50 = 77 nM | PMID: 15081034 | ER_alpha | |
ZINC12353750 | agonist | Compound 4f | IC50 = 2600 nM | EC50 = 240 nM | PMID: 15081034 | ER_alpha | |
ZINC26392428 | agonist | Compound 4l | IC50 = 1700 nM | EC50 = 120 nM | PMID: 15081034 | ER_alpha | |
ZINC26399859 | agonist | Compound 4e | IC50 = 5600 nM | EC50 = 140 nM | PMID: 15081034 | ER_alpha | |
ZINC34801132 | agonist | Compound 4h | IC50 = 2800 nM | EC50 = 270 nM | PMID: 15081034 | ER_alpha | |
ZINC53151203 | agonist | Compound 4a | IC50 = 2900 nM | EC50 = 160 nM | PMID: 15081034 | ER_alpha | |
CHEMBL330307 | antagonist | Compound 11f | IC50 = 71.2 nM | IC50 = 29.8 nM (66%) | PMID: 15125923 | ER_alpha | |
CHEMBL412907 | agonist | Compound 6c | IC50 = 99.0 nM | EC50 = 11.1 nM (93%) | PMID: 15125923 | ER_alpha | |
CHEMBL89994 | antagonist | Compound 11c | IC50 = 93.3 nM | IC50 = 86.6 nM (83%) | PMID: 15125923 | ER_alpha | |
CHEMBL93230 | antagonist | Compound 11i | IC50 = 21.3 nM | IC50 = 51.3 nM (96%) | PMID: 15125923 | ER_alpha | |
ZINC03816519 | agonist | Compound 2 | IC50 = 6 +/- 2 nM | % Activity = 126 % | PMID: 15341953 | ER_alpha | |
ZINC13520815 | agonist | 17b-estradiol | IC50 = 3.6 +/- 1.6 nM | PMID: 15341953 | ER_alpha | ||
ZINC16051646 | agonist | WAY-697 | IC50 = 2.2 +/- 1 nM | % Activity = 142 % | PMID: 15341953 | ER_alpha | |
ZINC16051648 | agonist | WAY-244 | IC50 = 14 +/- 3 nM | % Activity = 105 % | PMID: 15341953 | ER_alpha | |
ZINC28360400 | agonist | Compound 9 | IC50 = 10 +/- 2 nM | PMID: 15341953 | |||
ZINC28365864 | agonist | Compound 10 | IC50 = 0.5 +/- 0.2 nM | % Activity = 80 % | PMID: 15341953 | ||
ZINC28365964 | agonist | Compound 11 | IC50 = 3.3 +/- 1.4 nM | % Activity = 100 % | PMID: 15341953 | ||
ZINC28366344 | agonist | Compound 28 | IC50 = 3.2 +/- 0 nM | % Activity = 100 % | PMID: 15341953 | ||
ZINC28367107 | agonist | Compound 31 | IC50 = 1.1 +/- 0 nM | % Activity = 90 % | PMID: 15341953 | ||
ZINC28370566 | agonist | Compound 20 | IC50 = 4.0 +/- 1 nM | % Activity = 120 % | PMID: 15341953 | ||
ZINC28375865 | agonist | Compound 29 | IC50 = 6.6 +/- 2 nM | % Activity = 122 % | PMID: 15341953 | ||
ZINC28388341 | agonist | Compound 24 | IC50 = 7.9 +/- 6 nM | % Activity = 113 % | PMID: 15341953 | ||
ZINC28388344 | agonist | Compound 27 | IC50 = 6.0 +/- 1 nM | % Activity = 120 % | PMID: 15341953 | ||
ZINC28391251 | agonist | Compound 23 | IC50 = 2.0 +/- 1 nM | % Activity = 100 % | PMID: 15341953 | ||
ZINC28391660 | agonist | Compound 22 | IC50 = 10 +/- 3 nM | % Activity = 130 % | PMID: 15341953 | ||
CHEMBL360410 | agonist | cl-272 | IC50 = 3.5 +/- 1.3 nM | PMID: 15456246 | |||
ZINC13583645 | agonist | Compound 95 | IC50 = 1.4 +/- 0.4 nM | % activity = 117 % | PMID: 15456246 | ||
ZINC03817711 | agonist | Compound 62 | IC50 = 5 +/- 2 nM | PMID: 15456246 | ER_alpha | ||
ZINC03817763 | agonist | Erb-041 | IC50 (h)= 2.8 +/- 1.5 nM | % activity = 120 % | PMID: 15456246 | ||
ZINC13583638 | agonist | Compound 91 | IC50 (h)= 52 +/- 16 nM | % activity = 130 % | PMID: 15456246 | ||
ZINC13583640 | agonist | Compound 93 | IC50 (h)= 4.4 +/- 2.2 nM | % activity = 100 % | PMID: 15456246 | ||
ZINC13583650 | agonist | Compound 98 | IC50 (h)= 18 +/- 7 nM | % activity = 122 % | PMID: 15456246 | ||
ZINC13583653 | agonist | Compound 99 | IC50 (h)= 2.9 +/- 0.9 nM | % activity = 100 % | PMID: 15456246 | ||
ZINC13583669 | agonist | Compound 105 | IC50 = 190 +/- 88 nM | % activity = 83 % | PMID: 15456246 | ||
ZINC13583673 | agonist | Compound 108 | IC50 = 13 +/- 6 nM | % activity = 86 % | PMID: 15456246 | ||
ZINC13583676 | agonist | Compound 109 | IC50 = 11 +/- 6 nM | % activity = 100 % | PMID: 15456246 | ||
ZINC13583684 | agonist | Compound 112 | IC50 = 15 +/- 3 nM | % activity = 117 % | PMID: 15456246 | ||
ZINC13583689 | agonist | Compound 114 | IC50 = 14 +/- 10 nM | % activity = 158 % | PMID: 15456246 | ||
ZINC13583694 | agonist | Compound 116 | IC50 = 3.5 +/- 1.7 nM | % activity = 117 % | PMID: 15456246 | ||
ZINC13583710 | agonist | Compound 123 | IC50 = 1.9 +/- 0.6 nM | % activity = 120 % | PMID: 15456246 | ||
ZINC13583713 | agonist | Compound 124 | IC50 (h)= 3.1 +/- 1.4 nM | % activity = 117 % | PMID: 15456246 | ||
ZINC13583716 | agonist | Compound 125 | IC50 = 2.2 +/- 1.1 nM | % activity = 81 % | PMID: 15456246 | ||
ZINC28394513 | agonist | Compound 118 | IC50 (h)= 6.3 +/- 1.4 nM | % activity = 120 % | PMID: 15456246 | ||
ZINC28395140 | agonist | Compound 122 | IC50 = 23 +/- 6 nM | % activity = 131 % | PMID: 15456246 | ||
CHEMBL185907 | antagonist | Compound 21c | RBA = 0.10 +/- 0.002 % | PMID: 15537344 | |||
CHEMBL187972 | antagonist | Compound 23c | RBA = 0.07 +/- 0.01 % | PMID: 15537344 | |||
CHEMBL191066 | antagonist | Compound 24b | RBA = 0.05 +/- 0.006 % | PMID: 15537344 | |||
CHEMBL191210 | antagonist | Compound 25c | RBA = 0.07 +/- 0.006 % | PMID: 15537344 | |||
CHEMBL365110 | antagonist | Compound 22c | RBA = 0.07 +/- 0.01 % | PMID: 15537344 | |||
CHEMBL426073 | antagonist | Compound 24c | RBA = 1.7 +/- 0.06 % | PMID: 15537344 | |||
ZINC13584974 | antagonist | Compound 22a | RBA = 0.11 +/- 0.001 % | PMID: 15537344 | |||
ZINC13607930 | agonist | Compound 3a | EC50 = 3.55 µM (75 %) | PMID: 15658860 | ER_alpha | ||
ZINC13607934 | agonist | Compound 3c | EC50 = 0.60 µM (60%) | PMID: 15658860 | ER_alpha | ||
ZINC13607940 | agonist | Compound 5a | EC50 = 0.40 µM (103%) | PMID: 15658860 | ER_alpha | ||
ZINC00210379 | agonist | Compound 33 | EC50 = 195 nM | PMID: 15713407 | ER_alpha | ||
ZINC00517292 | agonist | Compound 31 | EC50 = 418 nM | PMID: 15713407 | ER_alpha | ||
ZINC00519098 | agonist | Compound 24 | EC50 = 38 nM | PMID: 15713407 | ER_alpha | ||
ZINC28118725 | agonist | Compound 22 | EC50 = 12 nM | PMID: 15713407 | ER_alpha | ||
ZINC28119115 | agonist | Compound 29 | EC50 = 180 nM | PMID: 15713407 | ER_alpha | ||
ZINC28119716 | agonist | Compound 11 | EC50 = 197 nM | PMID: 15713407 | ER_alpha | ||
ZINC28123535 | agonist | Compound 35 | EC50 = 183 nM | PMID: 15713407 | ER_alpha | ||
ZINC28127517 | agonist | Compound 20 | EC50 = 67 nM | PMID: 15713407 | ER_alpha | ||
ZINC28127985 | agonist | Compound 13 | EC50 = 485 nM | PMID: 15713407 | ER_alpha | ||
ZINC28128206 | agonist | Compound 21 | EC50 = 6 nM | PMID: 15713407 | ER_alpha | ||
ZINC28128361 | agonist | Compound 36 | EC50 = 25 nM | PMID: 15713407 | ER_alpha | ||
ZINC28128467 | agonist | Compound 15 | EC50 = 79 nM | PMID: 15713407 | ER_alpha | ||
ZINC28128474 | agonist | Compound 25 | EC50 = 46 nM | PMID: 15713407 | ER_alpha | ||
ZINC28129275 | agonist | Compound 37 | EC50 = 24 nM | PMID: 15713407 | ER_alpha | ||
ZINC28129302 | agonist | Compound 16 | EC50 = 275 nM | PMID: 15713407 | ER_alpha | ||
ZINC28129315 | agonist | Compound 32 | EC50 = 318 nM | PMID: 15713407 | ER_alpha | ||
ZINC28131038 | agonist | Compound 17 | EC50 = 3164 nM | PMID: 15713407 | ER_alpha | ||
ZINC28131195 | agonist | Compound 39 | EC50 = 9.2 nM | PMID: 15713407 | ER_alpha | ||
ZINC28131911 | agonist | Compound 40 | EC50 = 6.0 nM | PMID: 15713407 | ER_alpha | ||
ZINC28132349 | agonist | Compound 8 | EC50 = 305 nM | PMID: 15713407 | ER_alpha | ||
ZINC28135139 | agonist | Compound 19 | EC50 = 39 nM | PMID: 15713407 | ER_alpha | ||
ZINC28135609 | agonist | Compound 41 | EC50 = 1.4 nM | PMID: 15713407 | ER_alpha | ||
ZINC28135615 | agonist | Compound 42 | EC50 = 7.2 nM | PMID: 15713407 | ER_alpha | ||
ZINC28136021 | agonist | Compound 27 | EC50 = 40 nM | PMID: 15713407 | ER_alpha | ||
ZINC28136565 | agonist | Compound 18 | EC50 = 3050 nM | PMID: 15713407 | ER_alpha | ||
ZINC28136625 | agonist | Compound 9 | EC50 = 2825 nM | PMID: 15713407 | ER_alpha | ||
CHEMBL178097 | agonist | Compound 18b | RBA = 69 +/- 15 % | %efficacy = 78 % | PMID: 15715479 | ||
CHEMBL178148 | agonist | Compound 19b | RBA = 0.97 +/- 0.21 % | %efficacy = 57 % | PMID: 15715479 | ||
CHEMBL179526 | agonist | Compound 12e | RBA = 18.4 +/- 1.7 % | %efficacy = 66 % | PMID: 15715479 | ||
CHEMBL180071 | agonist | Compound 12c | RBA = 32.1 +/- 9.0 % | %efficacy = 88 % | PMID: 15715479 | ||
CHEMBL180517 | agonist | Compound 16b | RBA = 3.24 +/- 0.92 % | %efficacy = 63 % | PMID: 15715479 | ||
CHEMBL362609 | agonist | Compound 12f | RBA = 8.5 +/- 2.5 % | %efficacy = 85 % | PMID: 15715479 | ||
CHEMBL368225 | agonist | Compound 21b | RBA = 30.1 +/- 6.6 % | %efficacy = 82 % | PMID: 15715479 | ||
CHEMBL1627700 | agonist | Compound 43 | RBA = 240 +/- 130 % | 125 +/- 32 % | PMID: 15743187 | ||
CHEMBL1627711 | antagonist | Compound 47 | RBA = 125 +/- 98 | Ki = 0.3 +/- 0.2 nM | PMID: 15743187 | ||
CHEMBL1627715 | antagonist | Compound 76 | RBA = 82 +/- 16 % | Ki = 0.09 +/- 0.06 nM | PMID: 15743187 | ||
CHEMBL1627717 | antagonist | Compound 71 | RBA = 75 +/- 16 % | Ki = 0.3 +/- 0.2 nM | PMID: 15743187 | ||
CHEMBL1627718 | antagonist | Compound 60 | RBA = 88 +/- 17 % | Ki = 0.3 +/- 0.2 nM | PMID: 15743187 | ||
CHEMBL1627719 | antagonist | Compound 69 | RBA = 111 +/- 23 % | Ki = 0.3 +/- 0.2 nM | PMID: 15743187 | ||
CHEMBL1627720 | antagonist | Compound 62 | RBA = 32 +/- 17 % | Ki = 0.4 +/- 0.3 nM | PMID: 15743187 | ||
CHEMBL1627723 | antagonist | Compound 58 | RBA = 40 +/- 17 % | Ki = 0.3 +/- 0.1 nM | PMID: 15743187 | ||
CHEMBL1628006 | antagonist | Compound 74 | RBA = 93 +/- 18 % | Ki = 0.2 +/- 0.2 nM | PMID: 15743187 | ||
CHEMBL1628013 | antagonist | Compound 49 | RBA = 268 +/- 112 % | Ki = 0.1 +/- 0.04 nM | PMID: 15743187 | ||
ZINC03816518 | agonist | Way-202196 | IC50 = 2.7 +/- 1.9 nM | % activity = 120 % | PMID: 15943471 | ER_alpha | |
ZINC13645009 | agonist | Compound 15 | IC50 = 2.52 +/- 1.3 nM | % activity = 106 % | PMID: 15943471 | ER_alpha | |
ZINC13645024 | agonist | Compound 20 | IC50 = 17 +/- 2 nM | % activity = 100 % | PMID: 15943471 | ||
ZINC13645071 | agonist | Compound 35 | IC50 = 4.0 +/- 1 nM | % activity = 90 % | PMID: 15943471 | ||
ZINC13645083 | agonist | Compound 39 | IC50 = 10.6 +/- 0 nM | % activity = 100 % | PMID: 15943471 | ||
ZINC13645093 | agonist | Compound 42 | IC50 = 1.1 +/- 0.5 nM | % activity = 88 % | PMID: 15943471 | ||
ZINC13645096 | agonist | Compound 43 | IC50 = 2.5 +/- 1 nM | % activity = 100 % | PMID: 15943471 | ||
ZINC13645107 | agonist | Compound 46 | IC50 = 2.3 +/- 1.3 nM | % activity = 103 % | PMID: 15943471 | ||
ZINC13645114 | agonist | Compound 49 | IC50 = 6.0 +/- 3.3 nM | % activity = 143 % | PMID: 15943471 | ||
ZINC13645117 | agonist | Compound 50 | IC50 = 11 +/- 6 nM | % activity = 100 % | PMID: 15943471 | ||
CHEMBL306878 | agonist | NC-1 | RBA = 118 % | EC50 = 0.30 +/- 0.13 nM (75 +/- 6%) | PMID: 16162002 | ER_alpha | |
CHEMBL371192 | agonist | NC-4 | RBA = 0.4 % | EC50 = 512 +/- 182 nM (83 +/- 13%) | PMID: 16162002 | ER_alpha | |
CHEMBL69408 | agonist | NC-7 | RBA = 8 % | EC50 = 52 +/- 18 nM (90 +/- 7%) | PMID: 16162002 | ER_alpha | |
ZINC12353813 | agonist | NC-14 | RBA = 5 % | EC50 = 37 +/- 9 nM (64 +/- 7%) | PMID: 16162002 | ER_alpha | |
ZINC13555419 | agonist | NC-3 | RBA = 1772 % | EC50 = 0.30 +/- 0.083 nM (87 +/- 13%) | PMID: 16162002 | ER_alpha | |
ZINC13673469 | antagonist | NC-9 | RBA = 4 % | Ki = 1.3 +/- 0.4 nM | PMID: 16162002 | ||
ZINC13673471 | antagonist | NC-10 | RBA = 4 % | Ki = 0.19 +/- 0.0 nM | PMID: 16162002 | ER_alpha | |
ZINC13673475 | antagonist | NC-12 | RBA = 15 % | Ki = 0.49 +/- 0.18 nM | PMID: 16162002 | ||
ZINC13673477 | antagonist | NC-13 | RBA = 7 % | Ki = 1.3 +/- 0.3 nM | PMID: 16162002 | ER_alpha | |
ZINC13673479 | antagonist | NC-15 | RBA = 3 % | Ki = 0.91 +/- 0.27 nM | PMID: 16162002 | ||
ZINC13673481 | antagonist | NC-16 | RBA = 7 % | Ki = 2.2 +/- 0.73 nM | PMID: 16162002 | ||
ZINC13673485 | antagonist | NC-18 | RBA = 1 % | Ki = 15 +/- 7 nM | PMID: 16162002 | ||
ZINC13673486 | antagonist | NC-19 | RBA = 18 % | Ki = 0.46 +/- 0.16 nM | PMID: 16162002 | ER_alpha | |
ZINC13673488 | antagonist | NC-20 | RBA = 1 % | Ki =3.8 +/- 1.3 nM | PMID: 16162002 | ER_alpha | |
CHEMBL223065 | antagonist | Compound 12a | RBA = 1.7 +/- 0.2 % | PMID: 16279785 | ER_alpha | ||
CHEMBL389013 | antagonist | Compound 12b | RBA = 0.059 +/- 0.005 % | PMID: 16279785 | ER_alpha | ||
ZINC03804008 | agonist | Compound 21 | IC50 = 286 nM | EC50 = 153 nM | PMID: 16309907 | ||
ZINC03814414 | agonist | Compound 22 | IC50 = 10 nM | EC50 = 6 nM | PMID: 16309907 | ||
ZINC04081389 | agonist | Compound 23 | IC50 = 1754 nM | EC50 = 641 nM | PMID: 16309907 | ||
ZINC28568286 | agonist | Compound 7 | IC50 = 122 nM | EC50 = 68 nM | PMID: 16309907 | ||
ZINC28568460 | agonist | Compound 3 | IC50 = 11 nM | EC50 = 4.1 nM | PMID: 16309907 | ER_alpha | |
ZINC28568735 | agonist | Compound 5 | IC50 = 22 nM | EC50 = 8.7 nM | PMID: 16309907 | ||
ZINC28568740 | agonist | Compound 6 | IC50 = 83 nM | EC50 = 91 nM | PMID: 16309907 | ||
ZINC28568760 | agonist | Compound 4 | IC50 = 25 nM | EC50 = 3.8 nM | PMID: 16309907 | ||
ZINC28568788 | agonist | Compound 20 | IC50 = 381 nM | EC50 = 171 nM | PMID: 16309907 | ||
ZINC28568841 | agonist | Compound 13 | IC50 = 96 nM | EC50 = 39 nM | PMID: 16309907 | ||
ZINC28568877 | agonist | Compound 19 | IC50 = 17 nM | EC50 = 8 nM | PMID: 16309907 | ||
ZINC28569026 | agonist | Compound 16 | IC50 = 128 nM | EC50 = 148 nM | PMID: 16309907 | ||
ZINC28569825 | agonist | Compound 24 | IC50 = 230 nM | EC50 = 78 nM | PMID: 16309907 | ||
ZINC28569835 | agonist | Compound 26 | IC50 = 14 nM | EC50 = 24 nM | PMID: 16309907 | ER_alpha | |
ZINC28569921 | agonist | Compound 11 | IC50 = 1299 nM | EC50 = 827 nM | PMID: 16309907 | ||
ZINC28569925 | agonist | Compound 12 | IC50 = 16 nM | EC50 = 21 nM | PMID: 16309907 | ER_alpha | |
ZINC28569998 | agonist | Compound 10 | IC50 = 303 nM | EC50 = 188 nM | PMID: 16309907 | ||
ZINC28570424 | agonist | Compound 28 | IC50 = 782 nM | EC50 = 379 nM | PMID: 16309907 | ||
ZINC28570509 | agonist | Compound 9 | IC50 = 210 nM | EC50 = 67 nM | PMID: 16309907 | ||
ZINC28570599 | agonist | Compound 8 | IC50 = 212 nM | EC50 = 96 nM | PMID: 16309907 | ||
ZINC28950313 | agonist | Compound 25 | IC50 = 25 nM | EC50 = 31 nM | PMID: 16309907 | ||
ZINC34633744 | agonist | Compound 14 | IC50 = 361 nM | EC50 = 252 nM | PMID: 16309907 | ||
ZINC12353819 | agonist | Compound 1aaq | IC50 = 30661 nM | EC50 = 11685 nM | PMID: 16610787 | ||
ZINC13685353 | agonist | Compound 1aa | IC50 = 179 nM | EC50 = 76 +/- 8 nM | PMID: 16610787 | ER_alpha | |
ZINC13685377 | agonist | Compound 1ag | IC50 = 256 nM | EC50 = 190 nM | PMID: 16610787 | ER_alpha | |
ZINC13685406 | agonist | Compound 1ao | IC50 = 1275 nM | EC50 = 8870 nM | PMID: 16610787 | ER_alpha | |
ZINC13685409 | agonist | Compound 1ap | IC50 = 3970 nM | EC50 = 1638 nM | PMID: 16610787 | ||
ZINC13685439 | agonist | Compound 1aab | IC50 = 72848 nM | EC50 = 3843 nM | PMID: 16610787 | ||
ZINC13685443 | agonist | Compound 1aac | IC50 = 6994 nM | EC50 = 1985 nM | PMID: 16610787 | ER_alpha | |
ZINC13685446 | agonist | Compound 1aad | IC50 = 13426 nM | EC50 = 8776 nM | PMID: 16610787 | ||
ZINC13685465 | agonist | Compound 1aal | IC50 = 73677 nM | EC50 = 7579 +/- 511 nM | PMID: 16610787 | ||
ZINC13685468 | agonist | Compound 1aan | IC50 = 265 nM | EC50 = 62 nM | PMID: 16610787 | ER_alpha | |
ZINC13685476 | agonist | Compound 1aap | IC50 = 9536 nM | EC50 = 9406 nM | PMID: 16610787 | ||
ZINC13685480 | agonist | Compound 1aar | IC50 = 24 nM | EC50 = 4457 nM | PMID: 16610787 | ||
ZINC13685498 | agonist | Compound 1bd | IC50 = 79 nM | EC50 = 222 nM | PMID: 16610787 | ER_alpha | |
ZINC13685507 | agonist | Compound 1bf | IC50 = 515 nM | EC50 = 173 nM | PMID: 16610787 | ER_alpha | |
ZINC14972377 | agonist | Compound 1an | IC50 = 12298 nM | EC50 = 1966 nM | PMID: 16610787 | ||
ZINC14972381 | agonist | Compound 1aam | IC50 = 11979 nM | EC50 = 3804 nM | PMID: 16610787 | ||
CHEMBL379109 | agonist | Compound 28 | IC50 = 5.3 nM | EC50 = 11 nM | PMID: 16632357 | ||
CHEMBL209402 | agonist | Compound 21 | IC50 = 1.5 nM | EC50 = 4 nM | PMID: 16632357 | ||
CHEMBL209803 | agonist | Compound 20 | IC50 = 13 nM | EC50 = 2 nM | PMID: 16632357 | ||
CHEMBL378675 | agonist | Compound 23 | IC50 = 3.1 nM | EC50 = 5 nM | PMID: 16632357 | ||
CHEMBL208978 | agonist | Compound 27 | IC50 = 1.5 nM | EC50 = 40 nM | PMID: 16632357 | ||
CHEMBL209851 | agonist | Compound 19 | IC50 = 1.8 nM | EC50 = 4 nM | PMID: 16632357 | ||
CHEMBL379821 | agonist | Compound 29 | IC50 = 1.3 nM | EC50 = 2 nM | PMID: 16632357 | ||
CHEMBL376986 | agonist | Compound 26 | IC50 = 38 nM | EC50 = 5 nM | PMID: 16632357 | ||
CHEMBL381495 | agonist | Compound 12 | IC50 = 16 nM | EC50 = 20 nM | PMID: 16632357 | ||
ZINC04027099 | agonist | OBCP-3M | Ki = 12 nM | REP = 3.1 % | PMID: 16648639 | ||
CHEMBL209650 | agonist | Compound 24 | IC50 = 207 nM | EC50 = 210 nM (61%) | PMID: 16730987 | ||
CHEMBL211870 | agonist | Compound 34 | IC50 = 1.6 nM | EC50 = 0.8 nM (81%) | PMID: 16730987 | ER_alpha | |
CHEMBL211953 | agonist | Compound 9 | IC50 = 4.0 nM | EC50 = 1.7 nM (77%) | PMID: 16730987 | ER_alpha | |
CHEMBL377616 | agonist | Compound 2 | IC50 = 618 nM | EC50 = 76 nM (84%) | PMID: 16730987 | ||
CHEMBL379595 | agonist | Compound 28 | IC50 = 8.0 nM | EC50 = 1.5 nM (85%) | PMID: 16730987 | ||
ZINC00003345 | agonist | Compound 6 | IC50 = 4460 nM | EC50 = 935 nM (49%) | PMID: 16730987 | ||
ZINC03943533 | agonist | Compound 5 | IC50 = 7.2 nM | EC50 = 2.1 nM (91%) | PMID: 16730987 | ER_alpha | |
ZINC34028752 | agonist | Compound 13 | IC50 = 2.2 nM | EC50 = 0.7 nM (74%) | PMID: 16730987 | ||
ZINC34052804 | agonist | Compound 19 | IC50 = 2.8 nM | EC50 = 0.6 nM (79%) | PMID: 16730987 | ||
ZINC34633790 | agonist | Compound 23 | IC50 = 1.4 nM | EC50 = 0.8 nM (54%) | PMID: 16730987 | ||
ZINC34633793 | agonist | Compound 21 | IC50 = 7.7 nM | EC50 = 5.8 nM (69%) | PMID: 16730987 | ||
ZINC34633802 | agonist | Compound 35 | IC50 = 0.3 nM | EC50 = 0.2 nM (67%) | PMID: 16730987 | ER_alpha | |
ZINC34633805 | agonist | Compound 11 | IC50 = 7.7 nM | EC50 = 1.5 nM (70%) | PMID: 16730987 | ||
ZINC34633808 | agonist | Compound 17 | IC50 = 1.6 nM | EC50 = 0.9 nM (76%) | PMID: 16730987 | ER_alpha | |
ZINC34633839 | agonist | Compound 29 | IC50 = 1.5 nM | EC50 = 0.4 nM (86%) | PMID: 16730987 | ER_alpha | |
CHEMBL212392 | agonist | Compound 26 | IC50 = 81 nM | EC50 = 17 nM (89%) | PMID: 16777408 | ER_alpha | |
CHEMBL213070 | agonist | Compound 37 | IC50 = 43 nM | EC50 = 18 nM (82%) | PMID: 16777408 | ER_alpha | |
CHEMBL213529 | agonist | Compound 27 | IC50 = 18 nM | EC50 = 7.7 nM (90%) | PMID: 16777408 | ER_alpha | |
CHEMBL214200 | agonist | Compound 46 | IC50 = 7.4 nM | EC50 = 6.5 nM (82%) | PMID: 16777408 | ||
CHEMBL214693 | agonist | Compound 1 | IC50 = 1.8 nM | EC50 = 4 nM (81%) | PMID: 16777408 | ER_alpha | |
CHEMBL215802 | agonist | Compound 38 | IC50 = 5.7 nM | EC50 = 5.5 nM (85%) | PMID: 16777408 | ER_alpha | |
CHEMBL377457 | agonist | Compound 28 | IC50 = 27 nM | EC50 = 20 nM (96%) | PMID: 16777408 | ||
CHEMBL378883 | agonist | Compound 41 | IC50 = 11 nM | EC50 = 14 nM (78%) | PMID: 16777408 | ER_alpha | |
CHEMBL379314 | agonist | Compound 24 | IC50 = 24 nM | EC50 = 20 nM (86%) | PMID: 16777408 | ER_alpha | |
CHEMBL380188 | agonist | Compound 43 | IC50 = 58 nM | EC50 = 96 nM (77%) | PMID: 16777408 | ||
CHEMBL384709 | agonist | Compound 40 | IC50 = 3.2 nM | EC50 = 2.3 nM (83%) | PMID: 16777408 | ER_alpha | |
CHEMBL385028 | agonist | Compound 36 | IC50 = 60 nM | EC50 = 46 nM (90%) | PMID: 16777408 | ER_alpha | |
CHEMBL438616 | agonist | Compound 23 | IC50 = 3041 nM | EC50 = 475 nM(71%) | PMID: 16777408 | ||
ZINC34003569 | agonist | Compound 25 S | IC50= 5.7 nM | EC50 = 5.8 nM (99%) | PMID: 16777408 | ER_alpha | |
ZINC34052304 | agonist | Compound 29 R | IC50 = 242 nM | EC50 = 28 nM (88%) | PMID: 16777408 | ||
ZINC34052305 | agonist | Compound 29 S | IC50 = 5.1 nM | EC50 = 0.4 nM (91%) | PMID: 16777408 | ER_alpha | |
ZINC34633837 | agonist | Compound 39 S | IC50 = 11 nM | EC50 = 4.9 nM (76%) | PMID: 16777408 | ER_alpha | |
CHEMBL200799 | agonist | Compound 11 | IC50 = 15.1 +/- 3.04 nM | EC50 = 6.70 nM (93 %) | PMID: 16219463 | ||
CHEMBL371012 | agonist | Compound 14 | IC50 = 1.12 +/- 0.73 nM | EC50 = 1.09 nM (78 %) | PMID: 16219463 | ||
ZINC12353762 | agonist | SERBA-1 | Ki = 0.19 +/- 0.01 nM | EC50 = 0.66 +/- 0.04 nM (101 +/- 1.3 %) | PMID: 17034120 | ER_alpha | |
ZINC14972389 | agonist | SERBA-2 | Ki = 1.54 +/- 0.45 nM | EC50 = 3.61 +/- 1.51 nM (100 +/- 10%) | PMID: 17034120 | ER_alpha | |
ZINC14814929 | agonist | Compound 8a | IC50 = 863 +/- 292 nM | PMID: 17149865 | ER_alpha | ||
ZINC14970962 | agonist | Compound 8b | IC50 = 29 +/- 6 nM | PMID: 17149865 | ER_alpha | ||
ZINC14971010 | agonist | Compound 8h | IC50 = 37 +/- 5 nM | PMID: 17149865 | ER_alpha | ||
ZINC14971026 | agonist | Compound 8j | IC50 = 244 +/- 40 nM | PMID: 17149865 | ER_alpha | ||
ZINC13584996 | antagonist | Compound 2a | Ki = 139 nM | PMID: 17228884 | |||
ZINC13584998 | antagonist | Compound 3 | Ki = 48 nM | IC50 = 600 nM | PMID: 17228884 | ER_alpha | |
ZINC14970946 | antagonist | Compound 12a | Ki = 71 nM | IC50 = 40 nM | PMID: 17228884 | ER_alpha | |
ZINC14970950 | antagonist | Compound 12b | Ki = 178 nM | IC50 = 250 nM | PMID: 17228884 | ER_alpha | |
ZINC28896668 | agonist | Compound 8 | IC50 = 157 nM | EC50 = 132 nM | PMID: 17448656 | ER_alpha | |
ZINC28896673 | agonist | Compound 9 | IC50 = 322 nM | EC50 = 219 nM | PMID: 17448656 | ER_alpha | |
ZINC28896830 | agonist | Compound 11 | IC50 = 50 nM | EC50 = 28 nM | PMID: 17448656 | ||
ZINC28896834 | agonist | Compound 12 | IC50 = 854 nM | EC50 = 198 nM | PMID: 17448656 | ||
ZINC28896845 | agonist | Compound 25 | IC50 = 1460 nM | EC50 = 86 nM | PMID: 17448656 | ||
CHEMBL216355 | agonist | Compound 4b | Ki = 0.47 +/- 0.18 nM | PMID: 17485205 | |||
CHEMBL234460 | agonist | Compound 4a | Ki = 20.8 +/- 4.3 nM | PMID: 17485205 | |||
CHEMBL234462 | agonist | Compound 4h | Ki = 0.63 +/- 0.46 nM | PMID: 17485205 | |||
CHEMBL234463 | agonist | Compound 4d | Ki = 0.88 +/- 0.38 nM | PMID: 17485205 | |||
CHEMBL234633 | agonist | Compound 4g | Ki = 18.5 +/- 7.4 nM | PMID: 17485205 | |||
CHEMBL234637 | agonist | Compound 4i | Ki = 22.1 +/- 7.3 nM | PMID: 17485205 | |||
CHEMBL234638 | agonist | Compound 4c | Ki = 0.66 +/- 0.08 nM | PMID: 17485205 | |||
CHEMBL234639 | agonist | Compound 4e | Ki = 18.9 +/- 1.6 nM | PMID: 17485205 | |||
CHEMBL397775 | agonist | Compound 4f | Ki = 51 +/- 11 nM | PMID: 17485205 | |||
CHEMBL239723 | agonist | Compound 8a | IC50 = 0.22 µM | EC50 = 0.3 +/- 0.01 µM | PMID: 17574424 | ER_alpha | |
CHEMBL239938 | agonist | Compound 8b | IC50 = 0.083 µM | EC50 = 0.58 +/- 0.02 µM | PMID: 17574424 | ER_alpha | |
CHEMBL391619 | agonist | Compound 8c | IC50 = 0.14 µM | EC50 = 4.75 +/- 0.27 µM | PMID: 17574424 | ER_alpha | |
CHEMBL392029 | agonist | Compound 8d | IC50 = 0.23 µM | EC50 = 6.89 +/- 0.74 µM | PMID: 17574424 | ER_alpha | |
CHEMBL235828 | agonist | Compound 3b | Ki = 10.2 nM | PMID: 17614275 | |||
CHEMBL235829 | agonist | Compound 2d | Ki = 0.70 +/- 0.45 nM | PMID: 17614275 | |||
CHEMBL236045 | agonist | Compound 2e | Ki = 0.31 +/- 0.19 nM | PMID: 17614275 | |||
CHEMBL236718 | agonist | Compound 2b | Ki = 0.44 +/- 0.26 nM | PMID: 17614275 | |||
CHEMBL278936 | agonist | Compound 2a | Ki = 6.92 +/- 0.62 nM | PMID: 17614275 | |||
CHEMBL391532 | agonist | Compound 2c | Ki = 0.41 +/- 0.07 nM | PMID: 17614275 | |||
CHEMBL235386 | agonist | Compound 2c | Ki = 0.745 nM | PMID: 17662603 | |||
CHEMBL236086 | agonist | Compound 2b | Ki = 0.28 +/- 0.02 nM | PMID: 17662603 | |||
CHEMBL394338 | agonist | Compound 2d | Ki = 5.97 nM | PMID: 17662603 | |||
CHEMBL399832 | agonist | Compound 2a | Ki = 0.26 +/- 0.091 nM | PMID: 17662603 | |||
CHEMBL1628029 | agonist | Compound 2 | IC50 = 267 nM | PMID: 17696335 | ER_alpha | ||
CHEMBL236720 | agonist | Compound 4a | Ki = 0.53 +/- 0.04 nM | PMID: 17804226 | |||
CHEMBL393390 | agonist | Compound 4b | Ki = 118 nM | PMID: 17804226 | |||
CHEMBL440283 | agonist | androstenediol | IC50 = 9.9 nM | EC50 = 5.6 nM (77%) | PMID: 17890084 | ER_alpha | |
ZINC04805059 | agonist | Compound 14 | IC50 = 34 nM | EC50 = 210 nM (67%) | PMID: 17890084 | ||
ZINC04933906 | agonist | Compound 15 | IC50 = 9.4 nM | EC50 = 220 nM (59%) | PMID: 17890084 | ||
ZINC28950302 | agonist | Compound 4 | IC50 = 9 nM | EC50 = 69 nM (92%) | PMID: 17890084 | ||
ZINC28950308 | agonist | Compound 7 | IC50 = 64 nM | EC50 = 170 nM (84%) | PMID: 17890084 | ||
ZINC28950311 | agonist | Compound 9 | IC50 = 72 nM | EC50 = 31 nM (80%) | PMID: 17890084 | ||
ZINC28950315 | agonist | Compound 13 | IC50 = 120 nM | EC50 = 230 nM (59%) | PMID: 17890084 | ||
ZINC40424177 | agonist | Compound 4f | RBA = 0.102 % | EC50 = 11 nM (130%) | PMID: 18760603 | ER_alpha | |
ZINC40424544 | agonist | Compound 11b | RBA = 1.258 % | EC50 = 14 nM (114%) | PMID: 18760603 | ER_alpha | |
ZINC40428697 | agonist | Compound 8 | RBA = 0.063 % | EC50 = 5.2 nM (240%) | PMID: 18760603 | ER_alpha | |
ZINC40952765 | agonist | Compound 4l | RBA = 4.299 % | EC50 = 0.59 µM (64%) | PMID: 18760603 | ER_alpha | |
ZINC40952767 | agonist | Compound 4m | RBA = 1.912 % | EC50 = 0.12 µM (87%) | PMID: 18760603 | ER_alpha | |
ZINC40974788 | agonist | Compound 4i | RBA = 0.565 % | EC50 = 11 µM (77%) | PMID: 18760603 | ER_alpha | |
ZINC40975017 | agonist | Compound 4j | RBA = 18.134 % | EC50 = 0.067 µM (85%) | PMID: 18760603 | ER_alpha | |
ZINC40975931 | agonist | Compound 4h | RBA = 6.836 % | EC50 = 0.5 µM 71%) | PMID: 18760603 | ER_alpha | |
ZINC40976496 | agonist | Compound 12c | RBA = 0.004 % | EC50 = 12 nM (99%) | PMID: 18760603 | ER_alpha | |
ZINC40977295 | agonist | Compound 4g | RBA = 6.696 % | EC50 = 0.21 µM (109%) | PMID: 18760603 | ER_alpha | |
ZINC40845165 | agonist | Compound 3 | RBA = 7.01 +/- 1.00 % | EC50 = 4.8 nM | PMID: 19128016 | ER_alpha | |
ZINC40933971 | agonist | Compound 5 | RBA = 2.64 +/- 0.62 % | EC50 = 10 nM | PMID: 19128016 | ER_alpha | |
ZINC42922029 | agonist | Compound 32b | RBA = 7.5 +/- 1.6 % | EC50 = 0.61 nM | PMID: 19394116 | ER_alpha | |
ZINC40861576 | agonist | Compound 9e | RBA = 135 % | RTA = 146 % | PMID: 19167882 | ER_alpha | |
ZINC40862192 | agonist | Compound 9a | RBA = 21.5 % | RTA = 164 % | PMID: 19167882 | ||
ZINC40862503 | agonist | Compound 9d | RBA = 33.6 % | RTA = 149 % | PMID: 19167882 | ||
ZINC40428822 | agonist | Compound 11b | IC50 = 2048 nM | PMID: 19356928 | |||
ZINC40973106 | agonist | Compound 13 | IC50 = 15030 nM | PMID: 19356928 | |||
CHEMBL1098709 | agonist | Compound 3c | log IC50 = - 6.496 +/- 0.063 M | logEC50 = -7.461 +/- 0.087 M (97.0 +/- 5.0%) | PMID: 20408532 | ER_alpha | |
CHEMBL1098710 | agonist | Compound 3d | log IC50 = - 7.271 +/- 0.199 M | logEC50 = -7.645 +/- 0.142 M (112 +/- 7.3%) | PMID: 20408532 | ER_alpha | |
ZINC49112817 | agonist | Compound 3f | log IC50 = - 7.117 +/- 0.191 M | logEC50 = -7.574 +/- 0.108 M (111 +/- 6.4%) | PMID: 20408532 | ER_alpha | |
ZINC49115140 | agonist | Compound 3b | log IC50 = -6.596 +/- 0.102 M | logEC50 = -6.655 +/- 0.124 M (65.5 +/- 5.8%) | PMID: 20408532 | ER_alpha | |
ZINC49781421 | agonist | Compound 3e | log IC50 = - 6.301 +/- 0.078 M | logEC50 = -6.616 +/- 0.104 M(108 +/- 5.1%) | PMID: 20408532 | ER_alpha | |
ZINC49784137 | agonist | Compound 3a | log IC50 = -5.965 +/- 0.218 M | logEC50 = -6.756 +/- 0.081 M (105 +/-5.1%) | PMID: 20408532 | ER_alpha | |
CHEMBL1097449 | agonist | Compound 10ab | RBA = 0.16 % | Relative activation = 106.7 % | PMID: 20430632 | ER_alpha | |
CHEMBL1097457 | agonist | Compound 30ab | RBA = 0.18 % | Relative activation = 82.3 % | PMID: 20430632 | ER_alpha | |
CHEMBL1099199 | agonist | Compound 51ab | RBA = 0.04 % | Relative activation = 103.1 % | PMID: 20430632 | ER_alpha | |
ZINC13341109 | agonist | Compound 1 | IC50 = 1.8 +/- 0.3 µM | EC50 = 0.53 µM | PMID: 20493686 | ER_alpha | |
CHEMBL1082422 | agonist | Compound 2g | EC50 = 4.93 +/- 0.25 µM | PMID: 20553023 | ER_alpha | ||
CHEMBL1082742 | antagonist | Compound 3c | IC50 = 2.09 +/- 0.39 µM | PMID: 20553023 | ER_alpha | ||
CHEMBL1083881 | agonist | Compound 1b | EC50 = 4.07 +/- 0.48 µM | PMID: 20553023 | ER_alpha | ||
CHEMBL1083981 | antagonist | Compound 3a | IC50 = 0.0497 +/- 0.002 µM | PMID: 20553023 | ER_alpha | ||
ZINC00359736 | agonist | Compound 2k | EC50 = 34.9 +/- 0.76 µM | PMID: 20553023 | ER_alpha | ||
ZINC00383740 | antagonist | Compound 3b | IC50 = 1.52 +/- 0.55 µM | PMID: 20553023 | ER_alpha | ||
ZINC00383800 | antagonist | Compound 3e | IC50 = 3.91 +/- 1.24 µM | PMID: 20553023 | ER_alpha | ||
ZINC00385937 | agonist | Compound 2j | EC50 = 7.06 +/- 0.59 µM | PMID: 20553023 | ER_alpha | ||
ZINC04167143 | agonist | Compound 2c | EC50 = 0.0498 +/- 0.0018 µM | PMID: 20553023 | ER_alpha | ||
ZINC04183878 | agonist | Compound 1a | EC50 = 3.91 +/ 0.37 µM | PMID: 20553023 | ER_alpha | ||
ZINC04473320 | agonist | Compound 2i | EC50 = 5.77 +/- 0.29 µM | PMID: 20553023 | ER_alpha | ||
ZINC04656499 | agonist | Compound 2f | EC50 = 0.894 +/- 0.14 µM | PMID: 20553023 | ER_alpha | ||
ZINC04666452 | antagonist | Compound 3d | IC50 = 2.67 +/- 0.33 µM | PMID: 20553023 | ER_alpha | ||
ZINC05634978 | agonist | Compound 2h | EC50 = 5.36 +/- 0.73 µM | PMID: 20553023 | ER_alpha | ||
ZINC05730717 | agonist | Compound 2e | EC50 = 0.071 +/- 0.008 µM | PMID: 20553023 | ER_alpha | ||
ZINC05731164 | agonist | Compound 2d | EC50 = 0.0672 +/- 0.0144 µM | PMID: 20553023 | ER_alpha | ||
ZINC05731330 | agonist | Compound 2a | EC50 = 0.0338 +/- 0.0048 µM | PMID: 20553023 | ER_alpha | ||
ZINC06557091 | agonist | Compound 2b | EC50 = 0.0463 +/- 0.0045 µM | PMID: 20553023 | ER_alpha | ||
ZINC66102047 | agonist | Compound 1i | RBA = 42.8 +/- 5.5 % | RTA = 151 +/- 1 % | PMID: 21190382 | ||
ZINC66102049 | agonist | Compound 1k | RBA = 1.73 +/- 0.2 % | RTA = 95.4 +/- 4.0 % | PMID: 21190382 | ||
ZINC66103290 | agonist | Compound 1a | RBA = 21.5 +/- 4.6 % | RTA = 164 +/- 2 % | PMID: 21190382 | ||
ZINC66103292 | agonist | Compound 1b | RBA = 8.68 +/- 1.7 % | RTA = 196 +/- 3 % | PMID: 21190382 | ||
ZINC66103294 | agonist | Compound 1c | RBA = 136 +/- 7.3 % | RTA = 158 +/- 1 % | PMID: 21190382 | ||
ZINC66103296 | agonist | Compound 1d | RBA = 168 +/- 33 % | RTA = 189 +/- 7 % | PMID: 21190382 | ER_alpha | |
ZINC66103840 | agonist | Compound 5 | RBA = 118 +/- 4 % | RTA = 116.8 +/- 7.8 % | PMID: 21190382 | ER_alpha | |
ZINC66111808 | agonist | Compound 4 | RBA = 331 +/- 25 % | RTA = 126.7 +/- 7.9 % | PMID: 21190382 | ER_alpha | |
ZINC16697226 | agonist | Compound 18 | EC50 = 1.1 +/- 0.3 µM | PMID: 21381753 | |||
ZINC58651027 | agonist | Compound 8 | EC50 = 0.9 +/- 0.2 µM | PMID: 21381753 | ER_alpha | ||
ZINC64754982 | agonist | Compound 10 | EC50 = 3.8 +/- 0.7 µM | PMID: 21381753 | ER_alpha | ||
ZINC64754986 | agonist | Compound 19 | EC50 = 0.6 +/- 0.3 µM | PMID: 21381753 | ER_alpha | ||
ZINC71315822 | agonist | Compound 11 | EC50 = 1.6 +/- 0.4 µM | PMID: 21381753 | ER_alpha | ||
ZINC71316870 | agonist | Compound 14 | EC50 = 20 +/- 7 µM | PMID: 21381753 | ER_alpha | ||
ZINC71316889 | agonist | Compound 16 | EC50 = 30 +/- 17 µM | PMID: 21381753 | ER_alpha | ||
ZINC71318409 | agonist | Compound 9 | EC50 = 227 +/- 30 µM | PMID: 21381753 | ER_alpha | ||
ZINC71329506 | agonist | Compound 12 | ZC50 = 3.2 +/- 0.6 µM | PMID: 21381753 | ER_alpha | ||
ZINC71329876 | agonist | Compound 15 | EC50 = 60 +/- 10 µM | PMID: 21381753 | ER_alpha | ||
ZINC71296314 | agonist | Compound 17 | EC50 = 1.0 +/- 0.6 µM | PMID: 21381753 | |||
ZINC29136161 | agonist | Compound 1c | RBA = 4.21 +/- 0.66 % | EC50 = 11 nM (60%) | PMID: 21481497 | ER_alpha | |
ZINC71282407 | agonist | Compound 2b | RBA = 101 +/- 2 % | EC50 = 0.50 nM (80%) | PMID: 21481497 | ER_alpha | |
ZINC71294241 | agonist | Compound 2c | RBA = 130 +/- 25 % | EC50 = 0.23 nM (100%) | PMID: 21481497 | ER_alpha | |
ZINC71294751 | agonist | Compound 2d | RBA = 87.1 +/- 15.0 % | EC50 = 1.3 nM (100%) | PMID: 21481497 | ER_alpha | |
CHEMBL1836903 | agonist | Compound 7 | EC50 = 1100 nM (49%) | PMID: 21885279 | |||
CHEMBL1836904 | agonist | Compound 8 | EC50 = 418 nM (44%) | PMID: 21885279 | |||
CHEMBL1836905 | agonist | Compound 9 | EC50 = 84 nM (<30%) | PMID: 21885279 | |||
CHEMBL1836909 | agonist | Compound 13 | EC50 = 14 nM (43%) | PMID: 21885279 | |||
CHEMBL1836910 | agonist | Compound 14 | EC50 = 65 nM (36%) | PMID: 21885279 | |||
CHEMBL1836911 | agonist | Compound 15 | EC50 = 48 nM (49%) | PMID: 21885279 | |||
CHEMBL1836912 | agonist | Compound 16 | EC50 = 51 nM (45%) | PMID: 21885279 | ER_alpha | ||
CHEMBL1836913 | agonist | Compound 17 | EC50 = 1480 nM (86%) | PMID: 21885279 | |||
CHEMBL1836914 | agonist | Compound 18 | EC50 = 437 nM (82%) | PMID: 21885279 | |||
ZINC72124547 | agonist | Compound 4 | EC50 = 43 nM (104%) | PMID: 21885279 | ER_alpha | ||
ZINC72125890 | agonist | Compound 11 | EC50 = 79 nM (48%) | PMID: 21885279 | |||
ZINC72126103 | agonist | Compound 12 | EC50 = 110 nM (<20%) | PMID: 21885279 | |||
CHEMBL2031525 | agonist | Compound 11h | RBA = 0.297 +/- 0.08 % | EC50 = 760 nM (100 +/- 10%) | PMID: 22283328 | ER_alpha | |
CHEMBL2031528 | agonist | Compound 11k | RBA = 0.812 +/- 0.06 % | EC50 = 14000 nM (82 +/- 6%) | PMID: 22283328 | ER_alpha | |
CHEMBL2031529 | agonist | Compound 11l | RBA = 0.014 +/- 0.004 % | EC50 = 800 nM (82 +/- 20%) | PMID: 22283328 | ER_alpha | |
CHEMBL2022003 | agonist | Compound 1 | RBA = 0.09 +/- 0002 % | EC50 = 0.14 +/- 0.04 µM | PMID: 22464681 | ER_alpha | |
CHEMBL2022004 | agonist | Compound 2 | RBA = 0.06 +/- 0.01 | EC50 = 0.14 +/- 0.03 µM | PMID: 22464681 | ER_alpha | |
CHEMBL2022007 | agonist | Compound 5 | RBA = 0.08 +/- 0.02 % | EC50 = 0.32 +/- 0.04 µM | PMID: 22464681 | ER_alpha | |
CHEMBL2071176 | agonist | Compound 2b | EC50 = 1.93 +/- 0.048 µM | PMID: 22647217 | ER_alpha | ||
ZINC00271727 | agonist | Compound 1h | EC50 = 1.46 +/- 0.010 µM | PMID: 22647217 | ER_alpha | ||
ZINC00365042 | agonist | Compound 1k | EC50 = 13.4 +/- 0.59 µM | PMID: 22647217 | ER_alpha | ||
ZINC00365043 | agonist | Compound 2c | EC50 = 8.59 +/- 1.0 µM | PMID: 22647217 | ER_alpha | ||
ZINC00365190 | agonist | Compound 1j | EC50 = 4.95 +/- 0.13 µM | PMID: 22647217 | ER_alpha | ||
ZINC00365207 | agonist | Compound 1e | EC50 = 0.485 +/- 0.030 µM | PMID: 22647217 | ER_alpha | ||
ZINC00378186 | antagonist | Compound 3a | IC50 = 0.180 +/- 0.030 µM | PMID: 22647217 | ER_alpha | ||
ZINC00383745 | antagonist | Compound 3c | IC50 = 2.82 +/- 0.65 µM | PMID: 22647217 | ER_alpha | ||
ZINC00383772 | agonist | Compound 1a | EC50 = 2.69 +/- 0.25 µM | PMID: 22647217 | ER_alpha | ||
ZINC00383781 | agonist | Compound 1c | EC50 = 0.185 +/- 0.0006 µM | PMID: 22647217 | ER_alpha | ||
ZINC00383788 | agonist | Compound 1f | EC50 = 0.823 +/- 0.23 µM | PMID: 22647217 | ER_alpha | ||
ZINC00482170 | agonist | Compound 2e | EC50 = 28.9 +/- 10 µM | PMID: 22647217 | |||
ZINC01017110 | antagonist | Compound 3e | IC50 = 8.94 +/- 1.0 µM | PMID: 22647217 | ER_alpha | ||
ZINC01017164 | antagonist | Compound 3d | IC50 = 4.35 +/- 0.34 µM | PMID: 22647217 | ER_alpha | ||
ZINC01017209 | antagonist | Compound 3b | IC50 = 1.31 +/- 0.12 µM | PMID: 22647217 | ER_alpha | ||
ZINC02069659 | agonist | Compound 1b | EC50 = 0.0940 +/- 0.0040 µM | PMID: 22647217 | ER_alpha | ||
ZINC04666449 | agonist | Compound 1d | EC50 = 0.229 +/- 0.017 µM | PMID: 22647217 | ER_alpha | ||
ZINC04666501 | agonist | Compound 1i | EC50 = 1.98 +/- 0.38 µM | PMID: 22647217 | ER_alpha | ||
ZINC04666668 | agonist | Compound 1g | EC50 = 1.01 +/- 0.06 µm | PMID: 22647217 | ER_alpha | ||
ZINC08722915 | agonist | Compound 2a | EC50 = 0.123 +/- 0.022 µM | PMID: 22647217 | ER_alpha | ||
ZINC13481431 | agonist | Compound 2d | EC50 = 19.0 +/- 1.1 µM | PMID: 22647217 | ER_alpha | ||
CHEMBL2178792 | agonist | Compound 8l | RBA = 2.8 % | EC50 = 30 nM (88 +/- 14%) | PMID: 23043242 | ER_alpha | |
CHEMBL2178793 | agonist | Compound 8m | RBA = 4.1 % | EC50 = 23 nM (94 +/- 12%) | PMID: 23043242 | ER_alpha | |
CHEMBL2178797 | agonist | Compound 8b | RBA = 3.7 % | EC50 = 70 nM (101 +/- 1%) | PMID: 23043242 | ER_alpha | |
CHEMBL2179253 | agonist | Compound 8f | RBA = 3.1 % | EC50 = 63 nM (92 +/- 10%) | PMID: 23043242 | ER_alpha | |
ZINC00001290 | agonist | diethylstilbestrol | Ki = 0.05nM | PMID: 9048584 |
|
||
ZINC00902197 | antagonist | 4-hydroxytamoxifen | Ki = 0.04 nM | PMID: 9048584 | |||
ZINC03917379 | antagonist | ICI164,384 | Ki = 2.33 nM | PMID: 9216828 | |||
ZINC03940885 | antagonist | (R,R) THC | Ki = 3.6 nM | PMID: 9927308 | ER_alpha |